Abstract
Multiple myeloma is the second most common type of blood cancer and remains incurable despite advances in therapy. Current therapy for multiple myeloma includes a phased-approach, often consisting of initial induction therapy, consolidation and maintenance therapy. With an ever-growing landscape of treatment options, the approach to optimal therapy has become increasingly complex. Specifically, controversy surrounds the optimal use and duration of maintenance therapy. We conducted a comprehensive literature search to analyze the most current literature and to provide recommendations for maintenance therapy in multiple myeloma.
Original language | English (US) |
---|---|
Article number | e485 |
Journal | Blood cancer journal |
Volume | 6 |
Issue number | 10 |
DOIs | |
State | Published - Oct 21 2016 |
ASJC Scopus subject areas
- Hematology
- Oncology